Additionally, we analyzed the expression of CTLA‐4, PD‐1, LAG3, and TIGIT, which are inhibitory immune checkpoint molecules expressed in immune cells and exert inhibitory effects on the anti‐tumor functions of effector cells by binding to their respective ligands [35]. This evidence concerns the gene CTLA4 and neoplasm.